SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-010876
Filing Date
2022-05-04
Accepted
2022-05-04 16:44:42
Documents
64
Period of Report
2022-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dmtp20220331_10q.htm   iXBRL 10-Q 552644
2 EXHIBIT 31.1 ex_367015.htm EX-31.1 11944
3 EXHIBIT 31.2 ex_367016.htm EX-31.2 11921
4 EXHIBIT 32.1 ex_367017.htm EX-32.1 4838
5 EXHIBIT 32.2 ex_367018.htm EX-32.2 5032
11 graph01.jpg GRAPHIC 42586
  Complete submission text file 0001437749-22-010876.txt   3533434

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA dmac-20220331.xsd EX-101.SCH 42377
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dmac-20220331_cal.xml EX-101.CAL 31034
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dmac-20220331_def.xml EX-101.DEF 245830
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE dmac-20220331_lab.xml EX-101.LAB 216527
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dmac-20220331_pre.xml EX-101.PRE 272979
58 EXTRACTED XBRL INSTANCE DOCUMENT dmtp20220331_10q_htm.xml XML 433374
Mailing Address TWO CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447
Business Address TWO CARLSON PARKWAY SUITE 260 MINNEAPOLIS MN 55447 (763) 496-5454
DiaMedica Therapeutics Inc. (Filer) CIK: 0001401040 (see all company filings)

IRS No.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36291 | Film No.: 22892225
SIC: 2834 Pharmaceutical Preparations